J Urol Oncol > Volume 21(2); 2023 > Article |
|
Funding/Support
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019R1A2C1004046) (2020R1A2B5B03002344) (2020R1I1A3071568) (2021 R1G1A1092985) (2022R1I1A3069482), and Business for Cooperative R&D between Industry, Academy, and Research Institute funded Korea Small and Medium Business Administration (S3106172).
Author Contribution
Conceptualization: JHK, JNL; Data curation: JKK, JWC, YSH, SHC, BSK, HTK, THK, ESY, SHK, GSY, JNL, TGK; Formal analysis: JNL, TGK; Funding acquisition: none; Methodology: JHK; Project administration: TGK; Visualization: JKK; Writing - original draft: JHK; Writing - review & editing: JNL, TGK.
Values are presented as mean±standard deviation or number (%).
PSA, prostate-specific antigen; mpMRI, multiparametric magnetic resonance imaging; PIRADS, Prostate Imaging Reporting and Data System; ISUP, International Society of Urological Pathology; GGG, Gleason grade group; NCCN, National Comprehensive Cancer Network; LR, low risk; FIR, favorable intermediate risk; UIR, unfavorable intermediate risk; HR, high risk; PSM, positive surgical margin; N/A, not available.
Jae Hoon Kang
https://orcid.org/0000-0002-9885-6215
Jun-Koo Kang
https://orcid.org/0000-0002-8857-3406
Jae-Wook Chung
https://orcid.org/0000-0002-1055-2357
Yun-Sok Ha
https://orcid.org/0000-0003-3732-9814
Seock Hwan Choi
https://orcid.org/0000-0003-3796-2601
Bum Soo Kim
https://orcid.org/0000-0002-4873-3049
Hyun Tae Kim
https://orcid.org/0000-0002-4730-3776
Tae-Hwan Kim
https://orcid.org/0000-0003-4924-4826
Eun Sang Yoo
https://orcid.org/0000-0002-7442-6886
See Hyung Kim
https://orcid.org/0000-0002-3268-3091
Ghil Suk Yoon
https://orcid.org/0000-0002-9941-024X
Jun Nyung Lee
https://orcid.org/0000-0002-6342-9846
Tae Gyun Kwon
https://orcid.org/0000-0002-4390-0952